MedTrace Logo

Remote Symptom Review in Patients With Implantable Diagnostic Holter

NCT06431828 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2024-05-31

No results posted yet for this study

Summary

To study the clinical and organizational benefit of implementing a methodology for monitoring patients receiving an implantable diagnostic BIOMONITOR III holter and successive models, consisting of remote review of alerts sent by the device via the HOME MONITORING remote monitoring platform and the transmission of relevant patient symptoms through the use of a specific application installable on the patient's phone. The efficiency of this methodology will be compared with a control group consisting of monitoring through the usual clinical practice of the hospital.

Conditions

Interventions

OTHER

APP

The patients will download an app through which they will be able to report adverse events related to their cardiovascular health.

Sponsors & Collaborators

  • Fundacin Biomedica Galicia Sur

    collaborator OTHER

  • Fundacion Investigacion Interhospitalaria Cardiovascular

    collaborator OTHER

  • Andres Iñiguez Romo

    lead OTHER

Principal Investigators

  • Andrés Iñiguez Romo, MD, phD · Servicio Galego de Saude

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-04-22
Primary Completion
2025-05-31
Completion
2026-05-31

Countries

  • Spain

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06431828 on ClinicalTrials.gov